Dj Evaxion Biotech Offering Up To 5.25M Adss

European equities traded in the US as American depositary receipts opened the week higher late Monday morning, rising 0.41% to 1,307.69 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera and furniture maker Natuzzi , which rose 6.1% and 2.5% respectively. They were followed by semiconductor company Sequans Communications and telecommunications operator Telefonica , which were up 3.5% and 1.7% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech and biopharmaceutical company Grifols , which fell 4.3% and 0.8% respectively. They were followed by pharmaceutical companies Novo Nordisk and Ascendis Pharma , which dropped 1.8% and 0.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics and Adaptimmune Therapeutics , which advanced 5.1% each. They were followed by biopharmaceutical company Biodexa Pharmaceuticals B and oil and gas company BP , which rose 2.8% and 1.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group and pharmaceutical company Silence Therapeutics , which lost 7.2% and 5.2% respectively. They were followed by biopharmaceutical companies TC Biopharm and Amarin Corporation , which were down 10.9% and 2.6% respectively.

European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.76% to 1,307.21 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech company BioNTech and 3D printer company Materialise , which rose 4.4% and 4.1% respectively. They were followed by biopharmaceutical company Grifols and pharmaceutical company Novo Nordisk , which were up 0.6% and 0.1% respectively.

The decliners from continental Europe were led by biotech company Evaxion Biotech and semiconductor company Sequans Communications , which fell 5.2% and 4% respectively. They were followed by lender ING and software firm SAP , which dropped 2.2% and 1.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics and telecommunications operator Vodafone Group , which increased 4% and 2.8% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics and lender Barclays , which were up 0.9% and 0.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm and biotech company Trinity Biotech , which lost 15% and 3.7% respectively. They were followed by educational publishing company Pearson and biopharmaceutical company Verona Pharma , which were down 2.3% and 2% respectively.